CEMI - Chembio Diagnostics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
34,864
33,409
24,015
17,869
24,255
Cost of Revenue
22,838
21,427
12,921
9,418
13,769
Gross Profit
12,027
11,982
11,094
8,451
10,487
Operating Expenses
Research Development
9,006
8,526
8,555
8,428
6,378
Selling General and Administrative
14,257
11,101
9,021
7,596
7,663
Total Operating Expenses
23,263
19,627
17,577
16,023
14,041
Operating Income or Loss
-11,237
-7,645
-6,483
-7,572
-3,554
Interest Expense
-
-
3
0
1
Total Other Income/Expenses Net
-
-338
-
0
-5
Income Before Tax
-11,935
-7,933
-6,460
-7,546
-3,557
Income Tax Expense
-447
-68
-88
5,801
-1,160
Income from Continuing Operations
-11,488
-7,866
-6,372
-13,347
-2,397
Net Income
-11,488
-7,866
-6,372
-13,347
-2,397
Net Income available to common shareholders
-11,488
-7,866
-6,372
-13,347
-2,397
Reported EPS
Basic
-
-0.55
-0.52
-1.26
-0.25
Diluted
-
-0.55
-0.52
-1.26
-0.25
Weighted average shares outstanding
Basic
-
14,433
12,300
10,622
9,626
Diluted
-
14,433
12,300
10,622
9,626
EBITDA
-
-6,743
-5,180
-6,407
-2,184